Skip to main content

and
  1. Article

    Open Access

    Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

    Systemic therapies have been associated with clinically significant events (CSEs) in patients with unresectable hepatocellular carcinoma (uHCC). We evaluated the incidence of CSEs (bleeding, clotting, encephal...

    Daniel J. Simmons, Stephen J. Valerio, Darren S. Thomas in Advances in Therapy (2024)